ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
32 announcements
Subsidiary Shaily Medtech Devices was incorporated in Abu Dhabi on November 6, 2026. Initial subscription of AED 10 lakh remains pending.
Shaily hits a record quarter as Healthcare becomes its primary engine, contributing 55% of revenue and driving EBITDA margins to a high of 31.9%.
Q2 FY27 revenue Rs 319.5 Cr (+24%), EBITDA Rs 101.8 Cr (31.9% margin), PAT Rs 61.3 Cr (+20%). Healthcare (+78%) drives growth; GLP-1 capacity and Abu Dhabi facility expansion underway.
Shaily Engineering Plastics allotted 1,300 equity shares to employees on exercise of ESOPs at Rs. 732 per share under its 2019 plan. Issued paid-up capital rises to 4,59,96,548 shares of Rs. 2 each.
Shaily Engineering Plastics Ltd reported revenue from operations of ₹319.5 Cr (+24.5% YoY) and net profit of ₹61.3 Cr (+19.7% YoY) for Q2 FY27.
Shaily Engineering Plastics will hold a board meeting on 29th October 2026 to consider unaudited standalone and consolidated financial results for the quarter ended September 2026.
The company has filed its quarterly shareholding pattern under Regulation 31, disclosing promoter and public shareholding details as of the quarter ended September 30, 2026.
Shaily Engineering Plastics Ltd shareholders approved an enabling resolution to raise up to ₹500 Crore. The decision was part of seven resolutions passed at the Annual General Meeting.
Shaily Engineering Plastics Ltd shareholders approved a fundraise of up to ₹500 Crore at their AGM. Other approved resolutions include dividend declaration and re-appointment of the Managing Director.
Shaily Engineering Plastics Ltd held its 46th Annual General Meeting on 28th September 2026, transacting ordinary and special business items as per the notice.
CARE Ratings reaffirmed the long-term bank facility rating at 'CARE A+' and upgraded the short-term bank facility rating to 'CARE A1+'.
Shaily Engineering Plastics Limited has submitted its Annual Report for the financial year ended March 31, 2026, and scheduled its 46th Annual General Meeting.
Shaily Engineering Plastics has scheduled its 46th Annual General Meeting for September 28, 2026, via video conferencing to consider financial reports, dividends, and director appointments.
Shaily Engineering Plastics Ltd submitted its Business Responsibility and Sustainability Report for the financial year 2025-26, as required by SEBI regulations.
Shaily Engineering Plastics re-appointed Amit Mahendra Sanghvi as Managing Director for a 60-month term, effective from October 1, 2026.
Shaily Engineering Plastics approved its quarterly financial results, re-appointed Amit Mahendra Sanghvi as MD, and set a record date for the final dividend.
Shaily Engineering Plastics reported Q1 FY27 consolidated revenue of Rs. 280.7 Cr, up 14% YoY, driven primarily by strong performance in the healthcare segment (+85% YoY).
Shaily Engineering Plastics Ltd reported revenue from operations of ₹280.7 Cr (+13.8% YoY) and net profit of ₹48 Cr (+16.8% YoY) for Q1 FY27.
Shaily Engineering Plastics will hold a board meeting on 8th August 2026 to consider and approve its unaudited financial results for the quarter ending 30th June 2026.
Shaily Engineering Plastics Limited filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the period ended June 30, 2026.
Shaily reported Q4FY26 revenue growth of 9% YoY and 40% PAT growth. Strategy focuses on high-margin healthcare and new semiconductor/electronics segments.
Shaily Engineering launched a generic Semaglutide injection product in Canada using its ShailyPen Neo technology. The device also received USFDA tentative approval, expanding its global market footprint.
Shaily Engineering Plastics appointed Mr. Chi Hung Kam as KMP and new Internal and Cost Auditors. These appointments strengthen leadership and governance starting May 2026.
Shaily Engineering Plastics delivered record FY26 consolidated revenue of ₹991 Cr, driven by 139% YoY growth in the Healthcare segment and expansion into semiconductor trays.
Shaily Engineering Plastics allotted 40,155 shares under its 2019 ESOP scheme, realizing ₹2.93 Crore. This increases paid-up capital and reflects employee incentive program participation.
Shaily Engineering Plastics recommended a final dividend of Rs.3 per equity share for FY 2025-26. The record date will be announced in a subsequent meeting.
Shaily Engineering Plastics Ltd reported revenue from operations of ₹236.8 Cr (+8.7% YoY) and net profit of ₹40.2 Cr (+40.6% YoY) for Q4 FY26.
Shaily Engineering Plastics approved FY26 financial results and recommended a ₹3 dividend per share. The board also authorized a ₹500 Crore fund raise to fuel growth.
Shaily Engineering scheduled a board meeting on May 19, 2026, to approve audited financials. Directors will also consider a final dividend and potential fund raising.
Shaily Engineering Plastics Limited clarified that recent stock price movements are purely market-driven. The company confirmed compliance with Regulation 30 of SEBI (LODR) Regulations and stated no undisclosed material events exist.